|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02925351 |
|
Date of registration:
|
08/09/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
|
|
Scientific title:
|
The Biodistribution of 18F-Clofarabine in Patients With Autoimmune and Inflammatory Diseases |
|
Date of first enrolment:
|
January 25, 2016 |
|
Target sample size:
|
8 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02925351 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
|
|
Phase:
|
Early Phase 1
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Martin Allen-Auerbach |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
UCLA / Jonsson Comprehensive Cancer Center |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Must be 18 years or older.
- Diagnosed with an autoimmune and inflammatory disorder.
Exclusion Criteria
- Women of childbearing age will have to undergo a pregnancy test that will be provided
free of charge.
- Patients unable to undergo or comply with PET/CT scanning due to pre-existing medical
conditions including claustrophobia.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Crohn Disease
|
|
Inflammatory Disorder
|
|
Systemic Lupus Erythematosus
|
|
Autoimmune Disease
|
|
Takayasu Arteritis
|
|
Rheumatoid Arthritis
|
|
Intervention(s)
|
|
Radiation: Fluorine F 18 Clofarabine
|
|
Procedure: Computed Tomography
|
|
Procedure: Positron Emission Tomography
|
|
Primary Outcome(s)
|
|
Standardized Uptake Value
[Time Frame: Baseline up to 240 minutes after injection]
|
|
Secondary ID(s)
|
|
NCI-2016-01303
|
|
15-001600
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|